Skip to main content
Erschienen in: Obesity Surgery 10/2020

22.07.2020 | Original Contributions

Glucose-Lipid Metabolism in Obesity with Elevated Prolactin Levels and Alteration of Prolactin Levels After Laparoscopic Sleeve Gastrectomy

verfasst von: Xingchun Wang, Bingwei Ma, Guifang Li, Chunjun Sheng, Peng Yang, Jingyang Gao, Shen Qu

Erschienen in: Obesity Surgery | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We investigated the differences in metabolism between obesity with or without increased prolactin (PRL) and the change in PRL after laparoscopic sleeve gastrectomy (LSG).

Methods

Patients were divided into two groups: obesity with normal PRL (NP, n = 123) and high PRL (HP, n = 108). Glucose-lipid metabolism and inflammation were measured. A total of 115 patients with obesity (NP, n = 64; HP, n = 51) underwent LSG were recruited, and PRL was measured at 12 months after LSG.

Results

(1) Blood glucose (BG), total cholesterol (TCH), LDL, triglyceride, and TNF-α were lower in the HP than in the NP group in the cross-sectional study (all P < 0.05). (2) PRL was negatively associated with neck circumference, waist-to-hip ratio, systolic blood pressure, heart rate, basal metabolism rate (BMR), ALP, TCH, and LDL in all subjects. PRL levels were positively associated with weight, HC, and BMR in males but were negatively associated with ALT, AST, ALP, BG 30 min, BG 60 min, FFA, and TCH in females (all P < 0.05). (3) Regression analysis showed that PRL negatively correlated with ALP and LDL-C in the whole baseline (β = − 0.051, P = 0.002; β = − 1.372, P = 0.033). PRL was a negative factor for ALP in females and a positive factor for BMR2 in males (β = − 0.099, P = 0.041; β = 0.005, P = 0.006). (4) PRL decreased in the HP group and increased in the NP group at 12 months post-operation (all P < 0.05). Increased PRL was associated with a change in TCH in the NP group (P < 0.05).

Conclusion

Increased PRL resulted in improved glucose-lipid metabolism and chronic low-grade inflammation. LSG led to increased PRL in NP and decreased PRL in HP. Improved lipid was associated with increased PRL in NP after surgery.

Clinical Trial Registration Number

ChiCTR-OCS-12002381.
Literatur
1.
Zurück zum Zitat Kok P, Roelfsema F, Frolich M, et al. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab. 2004;89:4445–9.CrossRef Kok P, Roelfsema F, Frolich M, et al. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab. 2004;89:4445–9.CrossRef
2.
Zurück zum Zitat Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724–63.CrossRef Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724–63.CrossRef
3.
Zurück zum Zitat Marano RJ, Ben-Jonathan N. Minireview: extrapituitary prolactin: an update on the distribution, regulation, and functions. Mol Endocrinol. 2014;28:622–33.CrossRef Marano RJ, Ben-Jonathan N. Minireview: extrapituitary prolactin: an update on the distribution, regulation, and functions. Mol Endocrinol. 2014;28:622–33.CrossRef
4.
Zurück zum Zitat Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007;9:464–76.CrossRef Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007;9:464–76.CrossRef
5.
Zurück zum Zitat Manshaei N, Shakibaei F, Fazilati M, Salavati H, Negahdary M, Palizban A. An investigation of the association between the level of prolactin in serum and type II diabetes. Diabetol Metab Syndr 2018. Manshaei N, Shakibaei F, Fazilati M, Salavati H, Negahdary M, Palizban A. An investigation of the association between the level of prolactin in serum and type II diabetes. Diabetol Metab Syndr 2018.
6.
Zurück zum Zitat Ponce AJ, Galvan-Salas T, Lerma-Alvarado RM, et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine. 2020;67:331–43.CrossRef Ponce AJ, Galvan-Salas T, Lerma-Alvarado RM, et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine. 2020;67:331–43.CrossRef
7.
Zurück zum Zitat Ruiz-Herrera X, de Los Rios EA, Diaz JM, et al. Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males. Endocrinology. 2017;158:56–68.PubMed Ruiz-Herrera X, de Los Rios EA, Diaz JM, et al. Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males. Endocrinology. 2017;158:56–68.PubMed
8.
Zurück zum Zitat Bole-Feysot C, Goffin V, Edery M, et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19:225–68.CrossRef Bole-Feysot C, Goffin V, Edery M, et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19:225–68.CrossRef
9.
Zurück zum Zitat Freemark M, Fleenor D, Driscoll P, et al. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology. 2001;142:532–7.CrossRef Freemark M, Fleenor D, Driscoll P, et al. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology. 2001;142:532–7.CrossRef
10.
Zurück zum Zitat Kok P, Roelfsema F, Langendonk JG, et al. Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. Am J Physiol Endocrinol Metab. 2006;290:E218–24.CrossRef Kok P, Roelfsema F, Langendonk JG, et al. Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. Am J Physiol Endocrinol Metab. 2006;290:E218–24.CrossRef
11.
Zurück zum Zitat Mingrone G, Manco M, Iaconelli A, et al. Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery. Obesity. 2008;16:1831–7.CrossRef Mingrone G, Manco M, Iaconelli A, et al. Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery. Obesity. 2008;16:1831–7.CrossRef
12.
Zurück zum Zitat Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374:113–23.CrossRef Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374:113–23.CrossRef
13.
Zurück zum Zitat Qi L, Guo Y, Liu CQ, et al. Effects of bariatric surgery on glycemic and lipid metabolism, surgical complication and quality of life in adolescents with obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2017;13:2037–55.CrossRef Qi L, Guo Y, Liu CQ, et al. Effects of bariatric surgery on glycemic and lipid metabolism, surgical complication and quality of life in adolescents with obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2017;13:2037–55.CrossRef
14.
Zurück zum Zitat Reis LO, Zani EL, Saad RD, et al. Bariatric surgery does not interfere with sperm quality--a preliminary long-term study. Reprod Sci. 2012;19:1057–62.CrossRef Reis LO, Zani EL, Saad RD, et al. Bariatric surgery does not interfere with sperm quality--a preliminary long-term study. Reprod Sci. 2012;19:1057–62.CrossRef
15.
Zurück zum Zitat Reis LO, Favaro WJ, Barreiro GC, et al. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. Int J Androl. 2010;33:736–44.CrossRef Reis LO, Favaro WJ, Barreiro GC, et al. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. Int J Androl. 2010;33:736–44.CrossRef
16.
Zurück zum Zitat NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–61. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–61.
17.
Zurück zum Zitat Deitel M, Crosby RD, Gagner M. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg. 2008;18:487–96.CrossRef Deitel M, Crosby RD, Gagner M. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg. 2008;18:487–96.CrossRef
18.
Zurück zum Zitat Halbreich U, Kinon BJ, Gilmore JA, et al. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology. 2003;28(Suppl 1):53–67.CrossRef Halbreich U, Kinon BJ, Gilmore JA, et al. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology. 2003;28(Suppl 1):53–67.CrossRef
19.
Zurück zum Zitat Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6:168–75.CrossRef Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6:168–75.CrossRef
20.
Zurück zum Zitat Soares MJ, Cummings NK, Ping-Delfos WL. Energy metabolism and the metabolic syndrome: does a lower basal metabolic rate signal recovery following weight loss? Diabetol Metab Syndr. 2011;5:98–101.CrossRef Soares MJ, Cummings NK, Ping-Delfos WL. Energy metabolism and the metabolic syndrome: does a lower basal metabolic rate signal recovery following weight loss? Diabetol Metab Syndr. 2011;5:98–101.CrossRef
21.
Zurück zum Zitat Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130–9.CrossRef Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130–9.CrossRef
22.
Zurück zum Zitat Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008;29:1–41.CrossRef Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008;29:1–41.CrossRef
23.
Zurück zum Zitat Daimon M, Kamba A, Murakami H, et al. Association between serum prolactin levels and insulin resistance in non-diabetic men. PLoS One. 2017;12:e0175204.CrossRef Daimon M, Kamba A, Murakami H, et al. Association between serum prolactin levels and insulin resistance in non-diabetic men. PLoS One. 2017;12:e0175204.CrossRef
24.
Zurück zum Zitat Ling C, Hellgren G, Gebre-Medhin M, et al. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice. Endocrinology. 2000;141:3564–72.CrossRef Ling C, Hellgren G, Gebre-Medhin M, et al. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice. Endocrinology. 2000;141:3564–72.CrossRef
25.
Zurück zum Zitat Fleenor D, Arumugam R, Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res. 2006;66:101–10.PubMed Fleenor D, Arumugam R, Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res. 2006;66:101–10.PubMed
26.
Zurück zum Zitat Chirico V, Cannavo S, Lacquaniti A, et al. Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction. Clin Endocrinol. 2013;79:537–44.CrossRef Chirico V, Cannavo S, Lacquaniti A, et al. Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction. Clin Endocrinol. 2013;79:537–44.CrossRef
27.
Zurück zum Zitat Lemini M, Ruiz-Herrera X, Ledesma-Colunga MG, et al. Prolactin anterior pituitary expression and circulating levels are reduced in obese and diabetic rats: role of TGF-beta and TNF-alpha. Am J Physiol Regul Integr Comp Physiol. 2015;308:R792–9.CrossRef Lemini M, Ruiz-Herrera X, Ledesma-Colunga MG, et al. Prolactin anterior pituitary expression and circulating levels are reduced in obese and diabetic rats: role of TGF-beta and TNF-alpha. Am J Physiol Regul Integr Comp Physiol. 2015;308:R792–9.CrossRef
28.
Zurück zum Zitat Serri O, Li L, Mamputu JC, et al. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol. 2006;64:366–70. Serri O, Li L, Mamputu JC, et al. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol. 2006;64:366–70.
29.
Zurück zum Zitat Balasse E. Energy expenditure and obesity. Rev Med Brux. 1994;15:255–8.PubMed Balasse E. Energy expenditure and obesity. Rev Med Brux. 1994;15:255–8.PubMed
30.
Zurück zum Zitat Fetissov SO, Meguid MM, Sato T, et al. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol. 2002;283:R905–10.CrossRef Fetissov SO, Meguid MM, Sato T, et al. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol. 2002;283:R905–10.CrossRef
31.
Zurück zum Zitat Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357:354–7.CrossRef Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357:354–7.CrossRef
Metadaten
Titel
Glucose-Lipid Metabolism in Obesity with Elevated Prolactin Levels and Alteration of Prolactin Levels After Laparoscopic Sleeve Gastrectomy
verfasst von
Xingchun Wang
Bingwei Ma
Guifang Li
Chunjun Sheng
Peng Yang
Jingyang Gao
Shen Qu
Publikationsdatum
22.07.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 10/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04771-2

Weitere Artikel der Ausgabe 10/2020

Obesity Surgery 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.